Hubbard Cristin bought BMRN
March 17, 2025 · Form 4 insider transaction
Hubbard Cristin bought 30,880 shares of BioMarin Pharmaceutical Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
30,880
Price
$0.00
Total value
N/A
InsiderHubbard Cristin
Role—
SecurityStock Option (Right to Buy Common Stock)
Transaction codeA: Grant or award
Transaction dateMarch 17, 2025
Filing dateMarch 18, 2025
Shares owned after30,880
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Option grant vests 12/48th on March 17, 2026 and 1/48th on the 17th day of each month thereafter.